comparing XIENCE V

Related by string. * Comparing . COMPARING . Compared . Comparer . com pared : +#.# bn compared . BOPD NAR compared . comparing watermelons . FDIC DIF compared . -#.# bn compared / Xience : XIENCE V demonstrated . XIENCE V PROMUS Stent . PROMUS XIENCE V . XIENCE V Everolimus Eluting . XIENCE V drug eluting / VD . Vs . vs . VS : b v * . V CAST Music . Microsoft Hyper V . overturn Roe v. Wade * *

Related by context. Frequent words. (Click for all words.) 69 multicenter randomized double 67 Initiates Phase II 66 randomized multicenter 65 Completes Enrollment 65 Pivotal Trial 64 YOUR LOCAL ANIMAL SHELTER 64 placebo controlled randomized 64 blind multicenter 64 Initiate Phase 64 Receives Orphan Drug Designation 64 Phase III randomized 64 Pivotal Phase 64 Commences Phase 64 Meets Primary Endpoint 63 Randomised 63 multicenter prospective 63 MKC# 63 plus prednisone 63 double blinded randomized 62 J Am Coll 62 label multicenter 62 Vytorin combines 62 Pivotal Phase III 62 XIENCE V demonstrated 62 II Clinical Trial 62 multicenter randomized 62 Phase IIIb 62 BY ADRIAN NEMES 62 R sorafenib tablets 61 TAXUS ® 61 blinded placebo controlled 61 Daclizumab 61 phase IIb clinical 61 Phase III Trial 61 prospective multicenter 61 SPIRIT III 61 Pivotal Study 61 Phase III Clinical Trial 61 randomized #:# 61 Presents Positive 61 prospective randomized 60 relapsed refractory multiple myeloma 60 By Arek Sarkissian 60 refractory chronic lymphocytic 60 active comparator 60 PET FROM 60 TAXUS Liberte 60 Coronary Stent System 60 Announces FDA Clearance 60 Coronary Stent 60 patients undergoing percutaneous 60 Drug Eluting Stent 60 PROMUS 60 randomized double 60 NYHA Class II 60 multicenter clinical 59 Initiates Phase 59 TAXUS Express Stent 59 randomized Phase III 59 Clinical Trial Results 59 Patients Undergoing 59 Acute Myocardial Infarction 59 Improves Survival 59 metastatic hormone refractory 59 Renal Cell Carcinoma 59 drug eluting coronary stent 59 platinum chromium alloy 59 SPIRIT IV 59 Chronic Hepatitis C 59 Angiographic 59 BY DOUGLAS HANKS 59 Multicenter 59 Patient Enrollment 59 placebo controlled Phase 58 prospective randomized controlled 58 multicentre 58 EVEREST II 58 Cardiac Resynchronization Therapy 58 metastatic castrate resistant 58 relapsing multiple sclerosis 58 TAXUS Liberte Stent 58 Randomized controlled 58 Drug Shows Promise 58 Acute Ischemic Stroke 58 By DENES HUSTY 58 multicenter Phase 57 randomized placebo controlled 57 Dapagliflozin 57 Amrubicin 57 J Am Acad 57 Ixempra 57 By RYAN BOLAND 57 Metastatic Melanoma 57 primary hypercholesterolemia 57 plus dexamethasone 57 Phase Ib II 57 BiTE R 57 dose escalation clinical 57 Randomized 57 nonrandomized 57 liposomal formulation

Back to home page